Table 1.
miRNA regulation in diverse regions of the somatosensory nociceptive pathway in different chronic pain conditions
miRNA studieda | Pain model | Tissue studied | Time point studied | Observed expression change | Refs |
---|---|---|---|---|---|
miRNAs in peripheral nervous system | |||||
Neuropathic pain | |||||
miRNA-183 cluster (comprising miR-183, miR-182, and miR-96) | SNL in mice | DRGs | 14 days | Decreased | [10] |
SNC in mice | Sciatic nerves | 4 and 7 days following SNI | Decreased | [79] | |
miRNA-183 | SNL in rat | DRGs | 7 and 14 days | Decreased | [15] |
miRNA-21 | SNT in rat | DRGs | 7 days | Increased | [60] |
SNR in rat | DRGs | 4 days | Increased | [80] | |
SNC in mice | Sciatic nerves | 4 and 7 days | Increased | [79] | |
miR-7a | SNL in rat | Ipsilateral lumbar 5 (L5) DRGs | 14 days | Decreased | [58] |
miR-96 | CCI in rat | Ipsilateral DRG | Day 7–21 | Decreased | [62] |
miR-143 | SNT in mice | Ipsilateral DRG | 6 days | Decreased | [16] |
miR-1, miR-16, miR-206 | SNA in mice | Ipsilateral DRG | Day 1–3 | Increased | [18] |
miR-125b-5p, miR-30d-5p, miR-379-5p | SNL in rats genetically segregated to sense high or low neuropathic pain | Ipsilateral DRG | 3 days | Differentially regulated | [81] |
Inflammatory pain | |||||
miR-183, miR-124a | CFA-induced inflammatory muscle pain model in rat | Ipsilateral trigeminal ganglion | 4 h to 4 days | Decreased | [82] |
miR-134 | CFA-induced inflammatory pain model in rat | Ipsilateral DRGs | Days 1–14 | Decreased from 1 to 7 days and increased at 14 days | [83] |
miR-183 cluster, miR-146a | Knee-joint osteoarthritis (OA) model in rat | Ipsilateral lumbar DRGs and SDH | 2, 4, and 8 weeks | Decreased | [84,85] |
miR-143 | CFA model in mice | Ipsilateral DRGs | 2 days | Decreased | [16] |
miR-1, miR-16, miR-206 | CFA model in mice | Ipsilateral DRGs | 12 h to 7 days | Decreased | [18] |
Cancer-associated pain | |||||
miR-1a-3p, miR-544-3p, miR-34c-5p, and 23 other miRNAs | Bone metastasis model in mouse | Ipsilateral DRGs | 8 days | Increased | [9] |
miR-370-3p, miR-483-3p, miR-291b-5p, and 28 other miRNAs | Bone metastasis model in mouse | Ipsilateral DRGs | 8 days | Decreased | [9] |
miRNAs in spinal cord | |||||
miR-137, miR-181a, miR-219-2-3p, and 247 other miRNAs | Traumatic SCI in rat | SDH | 4 h and 1 and 7 days | Differential regulation | [86] |
miRNA-203 | Bilateral CCI in rat | SDH | 14 days | Decreased | [87] |
miR-103 | SNL in rat | SDH | Not available | Decreased | [34] |
miR-1 | SNA in mice | SDH | Days 1–3 | Decreased | [18] |
miR-1, miR-124, miR-129-1, miR-129-2 | SCI in rat | Whole spinal cord | 4 and 14 days | Decreased | [88] |
miR-223 | SCI in mice | Whole spinal cord | 6 h to 7 days | Increased from 6 h to day 3 | [89] |
miR-124a | SCI in mice | Whole spinal cord | 6 h to 7 days | Decreased from day 1 to 7 | [89] |
miR-21 | SCI in mice | Whole spinal cord | Days 4–35 | Increased at day 35 | [90] |
miR-146a | OA in rat | Lumbar SDH | 2 and 4 weeks | Decreased | [84] |
miR-124a | Intraplantar application of formalin or interleukin-1β (IL-1β) (an inflammatory mediator) in mice | SDH or in spinal microglia | Hours 1–48 | Decreased from 1 to 24 h, basal levels at 48 h | [35,57] |
miR-1, miR-16, miR-206 | CFA in mice | SDH | Days 1–7 | Increased | [18] |
miRNAs in brain regions involved in pain | |||||
miR-155, miR-223 | Model of facial inflammatory pain in mouse | Prefrontal cortex | Day 3 | Increased | [23] |
miR-200b, miR-429 | PNL model of neuropathic pain in mice | Nucleus accumbens | Day 7 after sciatic nerve ligation was found | Decreased | [24] |
miR-146a, miR-34c, miR-125b-5p, miR-1, and others | CCI in rat | Hippocampus | Days 7 and 14 | Decreased | [91] |
let-7 family members, miR-103, and others | CCI in rat | Hippocampus | Days 7 and 14 | Increased | [91] |
Abbreviations: SNL, spinal nerve ligation; SNC, sciatic nerve crush; SNI, spared nerve injury; SNT, sciatic nerve transaction; SNR, sciatic nerve resection; CCI, chronic constriction injury; SNA, sciatic nerve axotomy; DRG, dorsal root ganglion; OA, osteoarthritis; CFA, Freund's Complete Adjuvant; SCI, spinal cord contusion injury; PNL, partial nerve ligation.
For genome-wide expression studies, only miRNAs that were confirmed with an independent method are listed.